Issue 9 - The Cancer Letter

Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.

SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.

LOGIN SUBSCRIBE NOW

SEARCH DATE

SEARCH TEXT

Cancel

OK

Cancel

OK

Delete Account

Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below

Roche to acquire Flatiron Health for $2.1 billion,

Roche CEO O'Day: Our investment in Flatiron will accelerate their mission

PH.AI CEO Hyde: With Big Data, pharma will focus on the measurement of value

A phase III trial seeks to determine whether diet and exercise can cure breast cancer

In Brief

Frederick Lab and Georgetown launch research, education collaboration

Yale joins BMS International Immuno-Oncology Network

Fung and the Fox Chase BMT Program receives “Game Changer Award”

MD Anderson and RaySearch form alliance to advance radiation therapy

Clinical Roundup

NCCN guidelines for patients with HIV seek to reduce cancer care gaps

CancerCare publishes findings from oncology provider study

A third of patients with lymph node-positive penile cancer don't receive recommended care

Drugs & Targets

Lilly receives additional FDA approval for Verzenio for advanced breast cancer

Yisheng's biological product for pancreatic cancer gets Orphan Drug Designation

Recent Issues

Renew today!

Subscriber content

Never miss an issue!

Login